| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |